FDA approves new concentrated platelet rich plasma system (Helio)
Cytomedix Inc. received FDA clearance for the use of its Angel Concentrated Platelet Rich Plasma System for processing a small sample of blood or a mixture of blood and bone marrow aspirate.
The Angel Concentrated Platelet Rich Plasma (cPRP) System is intended for use in the clinic of intraoperatively at the point of care for the safe and rapid preparation of PRP from a small sample of whole blood or a small mixture of blood and bone marrow. According to a company press release, the cPRP system has high platelet yields, signific...
